XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.22.2

Business Combinations | 6 Months Ended
--- | ---
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract] |
Business Combinations | Business Combinations Home Health and Hospice On January 1, 2022, we acquired a 50% equity interest from Frontier Home Health and Hospice, LLC in a joint venture with Saint Alphonsus System (“Saint Alphonsus”) which operates home health and hospice locations in Boise, Idaho. The total purchase price was $15.9 million and was funded on December 31, 2021. This acquisition was made to enhance our existing joint venture relationship with Saint Alphonsus and expand our footprint in this geographic area. This transaction was not material to our financial position, results of operations, or cash flows. We accounted for this transaction under the acquisition method of accounting and reported the results of operations of the acquired locations from the date of acquisition. Assets acquired, liabilities assumed, and noncontrolling interests were recorded at their estimated fair values as of the acquisition date. Estimated fair values were based on various valuation methodologies including: an income approach using primarily discounted cash flow techniques for the noncompete and license intangible assets; and an income approach utilizing the relief-from-royalty method for the trade name intangible asset. The aforementioned income methods utilize management’s estimates of future operating results and cash flows discounted using a weighted average cost of capital that reflects market participant assumptions. For all other assets and liabilities, the fair value was assumed to represent carrying value due to their short maturities. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. All goodwill recorded reflects our expectations of favorable growth opportunities in the home health and hospice markets based on positive demographic trends. At least $14.4 million of the goodwill recorded as a result of this transaction is deductible for federal income tax purposes. The fair values recorded were based upon a preliminary valuation. Estimates and assumptions used in such valuation are subject to change, which could be significant, within the measurement period (up to one year from the acquisition date). We expect to continue to obtain information to assist us in determining the fair value of the net assets acquired at the acquisition date during the measurement period. The preliminary fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Cash and cash equivalents | $ | 0.7 |
Accounts receivable, net | 1.6 |
Operating lease right-of-use-assets | 0.3 |
Identifiable intangible assets: |
Noncompete agreement (useful life of 5 years) | 0.2 |
Trade name (useful life of 6 months) | 0.1 |
Licenses (useful lives of 10 years) | 0.9 |
Internal-use software (useful life of 3 years) | 0.1 |
Goodwill | 28.7 |
Total assets acquired | 32.6 |
Liabilities assumed: |
Current operating lease liabilities | 0.1 |
Accounts payable | 0.1 |
Accrued payroll | 0.2 |
Other current liabilities | 0.2 |
Long-term operating lease liabilities | 0.2 |
Total liabilities assumed | 0.8 |
Noncontrolling interests | 15.9 |
Net assets acquired | $ | 15.9 |
Information regarding the cash paid for the acquisition during each period presented is as follows (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Fair value of assets acquired | $ | — |  |  | $ | 11.9 |  |  | $ | 3.9 |  |  | $ | 11.9 |
Goodwill | — |  |  | 90.1 |  |  | 28.7 |  |  | 90.1 |
Fair value of liabilities assumed | — |  |  | (2.7) |  |  | (0.8) |  |  | (2.7) |
Fair value of noncontrolling interest owned by joint venture partner | — |  |  | (1.6) |  |  | (15.9) |  |  | (1.6) |
Cash paid for acquisition(1) | $ | — |  |  | $ | 97.7 |  |  | $ | 15.9 |  |  | $ | 97.7 |
———————— (1) As discussed above, the $15.9 million was paid on December 31, 2021; therefore, this amount is not included in the condensed consolidated statement of cash flows for the six months ended June 30, 2022. Pro Forma Results of Operations The following table summarizes the results of operations of the above mentioned acquisition from the date of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisition been January 1, 2021 (in millions):
| Net Operating Revenues |  | Net (Loss) Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to June 30, 2022 |  |  |
Home Health and Hospice | $ | 3.1 |  |  | $ | (0.1) |
Combined entity: Supplemental pro forma from 04/01/2022-06/30/2022 | 1,330.5 |  |  | 48.7 |
Combined entity: Supplemental pro forma from 04/01/2021-06/30/2021 | 1,289.7 |  |  | 113.3 |
Combined entity: Supplemental pro forma from 01/01/2022-06/30/2022 | 2,664.1 |  |  | 136.2 |
Combined entity: Supplemental pro forma from 01/01/2021-06/30/2021 | 2,522.4 |  |  | 220.8 |
The information presented above is for illustrative purposes only and is not necessarily indicative of results that would have been achieved if the acquisition had occurred as of the beginning of our 2021 reporting period. See Note 2, Business Combinations, to the consolidated financial statements accompanying the 2021 Form 10‑K for information regarding acquisitions completed in 2021.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI https://asc.fasb.org/topic&trid=2303972 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 5 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration